Van Eck Associates Corp Biomarin Pharmaceutical Inc Transaction History

Van Eck Associates Corp

$80.1 Billion
Q3 2024

A detailed history of Van Eck Associates Corp transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Van Eck Associates Corp holds 132,132 shares of BMRN stock, worth $8.68 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

132,132

Previous 133,522 1.04%

Holding current value

$8.68 Million

Previous $11 Million 15.88%

% of portfolio

0.01%

Previous 0.02%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 29, 2024	SELL	$69.02 - $93.84 $95,937 - $130,437	-1,390 Reduced 1.04%	132,132 $9.25 Million
Q2 2024 Jul 31, 2024	SELL	$74.43 - $92.22 $693,315 - $859,029	-9,315 Reduced 6.52%	133,522 $11 Million
Q1 2024 Apr 30, 2024	BUY	$83.81 - $99.0 $732,583 - $865,359	8,741 Added 6.52%	142,837 $12.5 Million
Q4 2023 Feb 05, 2024	SELL	$76.22 - $98.51 $1.6 Million - $2.07 Million	-20,975 Reduced 13.53%	134,096 $12.9 Million
Q3 2023 Nov 08, 2023	SELL	$85.07 - $94.48 $375,754 - $417,318	-4,417 Reduced 2.77%	155,071 $13.7 Million
Q2 2023 Aug 03, 2023	SELL	$86.68 - $100.3 $463,651 - $536,504	-5,349 Reduced 3.25%	159,488 $13.8 Million
Q1 2023 May 03, 2023	SELL	$87.74 - $117.27 $2.33 Million - $3.12 Million	-26,611 Reduced 13.9%	164,837 $16 Million
Q4 2022 Feb 08, 2023	BUY	$80.93 - $108.63 $4.32 Million - $5.8 Million	53,398 Added 38.68%	191,448 $19.8 Million
Q3 2022 Oct 27, 2022	SELL	$82.16 - $96.94 $3.43 Million - $4.04 Million	-41,721 Reduced 23.21%	138,050 $11.7 Million
Q2 2022 Aug 03, 2022	BUY	$71.48 - $86.85 $1.7 Million - $2.07 Million	23,834 Added 15.28%	179,771 $14.9 Million
Q1 2022 May 10, 2022	BUY	$74.28 - $92.69 $975,222 - $1.22 Million	13,129 Added 9.19%	155,937 $12 Million
Q4 2021 Jan 26, 2022	SELL	$71.72 - $91.47 $442,297 - $564,095	-6,167 Reduced 4.14%	142,808 $12.6 Million
Q3 2021 Nov 03, 2021	SELL	$74.77 - $85.47 $1.82 Million - $2.09 Million	-24,399 Reduced 14.07%	148,975 $11.5 Million
Q2 2021 Aug 10, 2021	SELL	$75.51 - $84.79 $675,512 - $758,531	-8,946 Reduced 4.91%	173,374 $14.5 Million
Q1 2021 May 13, 2021	SELL	$74.73 - $90.69 $799,087 - $969,748	-10,693 Reduced 5.54%	182,320 $13.8 Million
Q4 2020 Feb 09, 2021	BUY	$72.61 - $90.2 $1.69 Million - $2.1 Million	23,265 Added 13.71%	193,013 $16.9 Million
Q3 2020 Nov 12, 2020	SELL	$71.87 - $131.03 $2.42 Million - $4.42 Million	-33,697 Reduced 16.56%	169,748 $12.9 Million
Q2 2020 Aug 10, 2020	BUY	$79.55 - $124.22 $3.28 Million - $5.13 Million	41,280 Added 25.46%	203,445 $25.1 Million
Q1 2020 May 12, 2020	SELL	$71.37 - $96.85 $1.39 Million - $1.89 Million	-19,503 Reduced 10.74%	162,165 $13.7 Million
Q4 2019 Feb 13, 2020	BUY	$64.27 - $86.37 $159,003 - $213,679	2,474 Added 1.38%	181,668 $15.4 Million
Q3 2019 Nov 08, 2019	SELL	$67.4 - $85.11 $238,191 - $300,778	-3,534 Reduced 1.93%	179,194 $12.1 Million
Q2 2019 Aug 07, 2019	SELL	$80.35 - $93.9 $1.41 Million - $1.64 Million	-17,510 Reduced 8.74%	182,728 $15.7 Million
Q1 2019 May 13, 2019	BUY	$84.2 - $98.62 $784,154 - $918,448	9,313 Added 4.88%	200,238 $17.8 Million
Q4 2018 Feb 12, 2019	SELL	$80.14 - $106.07 $1.48 Million - $1.95 Million	-18,430 Reduced 8.8%	190,925 $16.3 Million
Q3 2018 Nov 13, 2018	BUY	$93.92 - $105.72 $1 Million - $1.13 Million	10,677 Added 5.37%	209,355 $20.3 Million
Q2 2018 Aug 13, 2018	SELL	$76.01 - $99.03 $2.94 Million - $3.84 Million	-38,734 Reduced 16.32%	198,678 $18.7 Million
Q1 2018 May 11, 2018	SELL	$77.67 - $92.63 $3.2 Million - $3.82 Million	-41,194 Reduced 14.79%	237,412 $19.2 Million
Q4 2017 Feb 12, 2018	SELL	$80.76 - $95.13 $6.78 Million - $7.98 Million	-83,901 Reduced 23.14%	278,606 $24.8 Million
Q3 2017 Nov 09, 2017	BUY	$80.6 - $94.95 $3.32 Million - $3.91 Million	41,145 Added 12.8%	362,507 $33.7 Million
Q2 2017 Aug 11, 2017	BUY	N/A	321,362	321,362 $29.2 Million

Others Institutions Holding BMRN

# of Institutions

637

Shares Held

177M

Call Options Held

2.01M

Put Options Held

1.28M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.2B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Van Eck Associates Corp, based on Form 13F filings with the SEC.

News

Stay updated on Van Eck Associates Corp with notifications on news.

Account

Van Eck Associates Corp Biomarin Pharmaceutical Inc Transaction History